Presentation TCT 2012 Yes: The Quantitative Threshold Should Be Lowered! Presenter: Maurice Sarano October 23, 2012
Presentation TCT 2012 When Should MVD be Managed Medically? Presenter: William Boden October 23, 2012
Presentation TCT 2012 TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial Presenter: Eberhard Grube October 23, 2012
Presentation TCT 2012 Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR Presenter: Hendrik Treede October 23, 2012
Presentation TCT 2012 TCT-87. Safety and Efficacy of the MitraClip for the Treatment of Patients with a Dilated Left Ventricle and Functional Mitral Regurgitation Presenter: Anita Asgar October 23, 2012
Presentation TCT 2012 Pathogenesis of Vulnerable Plaque 2012: What's New? Presenter: Renu Virmani October 23, 2012
Presentation TCT 2012 Acute Success Rates, Complication, and Long-term Stroke Risks After AF Ablation: A Critical Appraisal of a Mixed Literature Presenter: Shephal Doshi October 23, 2012
Presentation TCT 2012 TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in... Presenter: Yoshinobu Onuma October 23, 2012
Presentation TCT 2012 Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con! Presenter: Andrej Schmidt October 23, 2012
Presentation TCT 2012 Abluminus (Envision Scientific) Program Update Presenter: Sameer Dani October 23, 2012